• Publications
  • Influence
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
Summary Cerebral small vessel disease (SVD) is a common accompaniment of ageing. Features seen on neuroimaging include recent small subcortical infarcts, lacunes, white matter hyperintensities,Expand
  • 2,209
  • 158
  • PDF
Diagnosis and management of dementia with Lewy bodies
The dementia with Lewy bodies (DLB) Consortium has revised criteria for the clinical and pathologic diagnosis of DLB incorporating new information about the core clinical features and suggesting improved methods to assess them. Expand
  • 3,268
  • 146
  • PDF
Diagnosis and management of dementia with Lewy bodies
The Dementia with Lewy Bodies (DLB) Consortium has refined its recommendations about the clinical and pathologic diagnosis of DLB, updating the previous report, which has been in widespread use forExpand
  • 694
  • 27
  • PDF
Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
Parkinson's disease is a common neurodegenerative disorder primarily characterized by rigidity, tremor and bradykinesia. Cognitive impairment and neuropsychiatric symptoms are frequent in Parkinson'sExpand
  • 542
  • 25
EFNS guidelines for the diagnosis and management of Alzheimer’s disease
Background and objectives:  In 2008 a task force was set up to develop a revision of the European Federation of the Neurological Societies (EFNS) guideline for the diagnosis and management ofExpand
  • 421
  • 24
  • PDF
The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale. Two methods to assess fluctuating confusion in dementia.
BACKGROUND The identification of fluctuating confusion is central to improving the differential diagnosis of the common dementias. AIMS To determine the value of two rating scales to measureExpand
  • 324
  • 21
Donepezil and memantine for moderate-to-severe Alzheimer's disease.
BACKGROUND Clinical trials have shown the benefits of cholinesterase inhibitors for the treatment of mild-to-moderate Alzheimer's disease. It is not known whether treatment benefits continue afterExpand
  • 492
  • 20
  • PDF
Diagnostic Criteria for Vascular Cognitive Disorders: A VASCOG Statement
Background:Several sets of diagnostic criteria have been published for vascular dementia since the 1960s. The continuing ambiguity in vascular dementia definition warrants a critical reexamination.Expand
  • 314
  • 20
  • PDF
Aromatherapy as a safe and effective treatment for the management of agitation in severe dementia: the results of a double-blind, placebo-controlled trial with Melissa.
BACKGROUND Behavioral and psychological symptoms in dementia are frequent and are a major management problem, especially for patients with severe cognitive impairment. Preliminary reports haveExpand
  • 366
  • 20
Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study
BACKGROUND Dementia with Lewy bodies (DLB) needs to be distinguished from other types of dementia because of important differences in patient management and outcome. Current clinically basedExpand
  • 467
  • 19